ANDA 86358, held by Bristol Laboratories. Methotrexate Sodium.
As of Nov 21, 2026, ANDA 86358 (Mexate), held by Bristol Laboratories, was first approved by FDA on Sep 5, 1979, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 5, 1979 | Original application | Approved | None posted |
| MexateEQ 20MG BASE/VIAL ยท injectable;injection | Methotrexate Sodium | DiscontinuedReference drug |
| MexateEQ 50MG BASE/VIAL ยท injectable;injection | Methotrexate Sodium | DiscontinuedReference drug |
| MexateEQ 100MG BASE/VIAL ยท injectable;injection | Methotrexate Sodium | DiscontinuedReference drug |
| MexateEQ 250MG BASE/VIAL ยท injectable;injection | Methotrexate Sodium | DiscontinuedReference drug |
| Jul 12, 1989 | Supplement 27Labeling | Approved | None posted |
| Apr 13, 1988 | Supplement 26Manufacturing | Approved | None posted |
| Jul 27, 1987 | Supplement 24Manufacturing | Approved | None posted |
| Jul 27, 1987 | Supplement 17Manufacturing | Approved | None posted |
| Dec 13, 1983 | Supplement 12Manufacturing | Approved | None posted |
| Dec 1, 1982 | Supplement 9Manufacturing | Approved | None posted |
| Dec 1, 1982 | Supplement 8Manufacturing | Approved | None posted |
| Dec 1, 1982 | Supplement 6Manufacturing | Approved | None posted |
| Jul 2, 1982 | Supplement 7Manufacturing | Approved | None posted |
| Sep 5, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters